1 / 27

Lecture 26. Prevention and Control -- Vaccines

Lecture 26. Prevention and Control -- Vaccines. Flint et al., chapter 19, pp. 703 - 725. How do we acquire immunity?. Passive Immunity in Infants. Artificial Passive Immunity. Gamma globulin Ig’s from pooled blood of at least 1,000 human donors variable content non-specific

Download Presentation

Lecture 26. Prevention and Control -- Vaccines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lecture 26. Prevention and Control -- Vaccines Flint et al., chapter 19, pp. 703 - 725

  2. How do we acquire immunity?

  3. Passive Immunity in Infants

  4. Artificial Passive Immunity • Gamma globulin • Ig’s from pooled blood of at least 1,000 human donors • variable content • non-specific • Specific immune globulin (SIG) • higher titers of specific antibodies • Antisera and antitoxins of animal origin

  5. Antibody and effector T-cells are the basis of protective immunity • Primary infection stimulates an initial immune response. • A second infection is “inapparant” because it provokes no symptoms. • However, it does re-stimulate and fine tune the immune response. • Years later, memory B- and T-cells can become reactivated upon infection, protecting the individual from disease

  6. Artificial Active Immunity • Vaccination (Immunization) • exposing a person to material that is antigen but NOT pathogenic.

  7. History of Vaccination: Smallpox • Smallpox killed or maimed 10% of humankind. • Killed > 300,000,000 people in the 20th century alone • Ancient Chinese history: a once in a lifetime disease. • 11th century China and India: “Variolation” • Scratch a healthy person with pus from infected person • If they don’t die, they are immune for life

  8. Vaccination • May 14, 1796, Edward Jenner • Noted that milkmaids got cowpox, but not smallpox. • Injected pus from a cowpox lesion under the skin of a child • Waited 2 weeks • Deliberately infected the child with smallpox. • The boy survived • (Today, Jenner would be majorly sued, would lose his license, be put on trial, get a good lawyer, write a book, and do the talk show circuit…Just like Michael Jackson’s doctor!)

  9. History of Vaccination • Despite Jenner’s success, it took 100 years til the next vaccine. • 1881, Louis Pasteur: coined the word Vaccine. • Used dried spinal cord from rabid rabbit to create a rabies vaccine. • Also developed vaccines to fowl cholera and anthrax • July 6, 1885: 9 year old Joseph Meister who was badly bitten by a rabid dog. • Although Pasteur was not a licensed physician and faced legal risks, the boy would most certainly have died without treatment like many before him. • Pasteur decided to treat the boy nevertheless and inoculated Joseph with rabies vaccine that had been tested only on dogs previously. • The risk paid off and the boy recovered dramatically.

  10. Large scale vaccination programs Fig. 19.1 • Dramatic improvements in public health. • Nobody in this room has had… • Smallpox, Polio, Measles, Chickenpox • Mumps, Rubella • …Because of vaccination • Smallpox is the only human disease to ever be eradicated

  11. Characteristics of a good vaccine • Safe • Few side effects • Give long lasting, appropriate protection • Low in cost • Stable with long shelf life (no special storage requirements) • Easy to administer • Inexpensive • Public must see more benefit than risk

  12. Types of vaccines • whole agent • subunit • recombinant • individual parts alone

  13. epitopes epitopes Whole agent vaccines -- Killed using heat or formaldehyde Killed virus Live virus Inactivated polio vaccine (Salk) Influenza (Classic)

  14. oral polio vaccine (Sabin), MMR (measles, mumps, rubella) Influenza -- Flumist TM Whole agent vaccines -- Attenuated • attenuated - a process that lessens the virulence of a microbe

  15. Vaccines stimulate immune memory • Killed virus vaccine requires multiple doses (booster shots) to adequately stimulate a protective immune response • Live virus vaccines replicate in the host. • No requirement for boosters.

  16. Attenuation of viruses by passage through non-human cells • Pathogenic virus isolated from patient, grown in human cells • Infect monkey cells with cultured virus • Virus acquires many mutations that allow it to grow well in monkey cells • Mutations make the virus unable to grow well in human cells •  Vaccine candidate 1 2 3 4

  17. Advantages for live vaccines • multiply like natural organism • require fewer doses and boosters • long-lasting • Disadvantages for live vaccines • special storage • back mutation • side effects

  18. Live attenuated Sabin oral poliovirus vaccine

  19. Construction of recombinant attenuated virus • Isolate virus • Clone genome • Isolate virulence gene • Mutate or delete virulence gene • Resulting virus is • Viable • Immunogenic • Not virulent • Can be used as a vaccine

  20. Subunit vaccines • Single antigen or mixture of antigens • Safer (cannot reproduce) • However, often less effective than whole agent vaccines • Can be costly • Always require boosters

  21. Overcoming Subunit vaccine problems • Multiple doses - booster shots • Use adjuvants • prolongs stimulation of immune response • works by trapping the antigens in a chemical complex and releases them slowly

  22. Vaccine delivery systems and adjuvants ISCOMS as peptide delivery systems Fig. 19.9

  23. Recombinant vaccines • Genetic engineering approach • Hepatitis B • Vaccina or adenovirus alteration

  24. Create a recombinant plasmid containing a gene encoding a specific antigen. • Engineer in sequences • Enabling it to be expressed in humans • Passaged through bacteria • Introduce it into humans • Let the human cells produce the antigen • Present it to T-cells • Provoke immune response DNA vaccines

  25. Representative results of DNA vaccine trials

More Related